WHO ICTRP trial
A Safety, Tolerability, Pharmacokinetic and Formulation exploratory Study of a…
ChiCTR-TNC-12002605 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TNC-12002605 |
|---|---|
| Public title | A Safety, Tolerability, Pharmacokinetic and Formulation exploratory Study of a Single Oral Dose of W28F in Healthy Volunteers |
| Scientific title | Safety, Tolerability and Pharmacokinetics of a Single Oral Dose of W28F: A Randomized, Open and Non-Controlled Study in Healthy Volunteers |
| Primary sponsor | Shanghai Xuhui Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | IV (Phase IV study) |
| Countries | China |
| Conditions | HBV |
| Interventions | 50mg 100mg 200mg 300mg:W28F |
| Registration date | Aug 1, 2012 |
| Target size | 50mg 100mg 200mg 300mg:17 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: